Candriam Equities L Oncology Impact R/ LU1864482861 /
NAV16/05/2024 | Chg.+0.1800 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
191.3300USD | +0.09% | paying dividend | Equity Worldwide | Candriam ▶ |
NAV16/05/2024 | Chg.+0.1800 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
191.3300USD | +0.09% | paying dividend | Equity Worldwide | Candriam ▶ |